NEWS

— Financing proceeds to advance ArunA Bio’s neural exosome therapies for neurodegenerative diseases and partnering activities — — ArunA Bio establishes an office in Research Triangle Park, NC — Athens, GA; Research Triangle Park, NC – July 24, 2019—ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases,…

Proceeds Will Fund Pivotal Validation Study of Company’s Blood-based Test for the Screening of Colorectal Cancer Platform Has Potential for Use in Multiple Cancer Types and Enhanced Drug Development by Characterizing Tumor and Immune Signatures July 24, 2019 09:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Freenome, a biotechnology company that has pioneered the most…

Unites Four of the Top US Clinical Research Facilities to Reduce Time and Cost for New Drug Development SALT LAKE CITY, July 18, 2019 /PRNewswire/ —  CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announces the creation of their Centers of Excellence company, which unites four of the most experienced clinical research units in the country to design…

ATLANTA (July 12, 2019) – Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. Sharecare has named Quest its preferred laboratory partner for its comprehensive digital…

Washington, D.C. (July 11, 2019) – BIO’s President and CEO Jim Greenwood issued the following statement after it was reported that the Trump administration is withdrawing its proposed rebate rule that would have required savings from drugmakers’ rebates be passed along to seniors enrolled in the Medicare drug benefit program: “The administration has abandoned one of the only…

ATLANTA, Ga., July 8, 2019 /PRNewswire/ — Intent Solutions, an Atlanta-based company that provides technology to improve prescription drug safety and adherence, announced today that it is partnering with the University of Kentuckyin a $15 million federal grant program aimed at eliminating Hepatitis C in one eastern Kentucky county hardest hit by the disease.  Intent Solutions recently signed a contract with the University of Kentucky to…